Related Experiment Video
Updated: Mar 11, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease
C Papadopoulos1, G K Papadimas1, H Michelakakis2
1Eginition Hospital, University of Athens, School of Medicine, Greece.
Background/Aims:
Pompe disease is a rare metabolic disorder caused by deficiency of the lysosomal enzyme acid alpha-glycosidase (GAA). The late onset form of the disease is characterized by muscle weakness and respiratory involvement of variable severity. The aim of this short communication is to highlight the clinical variability of Pompe disease within siblings suffering from the disease.
Case Reports:
We report three pairs of siblings with late-onset Pompe disease presenting with different clinical phenotypes within the spectrum of disease phenotypes.
Conclusion:
Clinical manifestations in Pompe disease within the same family can be very different. Clinicians should investigate patients' siblings for symptoms throughout the entire spectrum of the disease in order to avoid delays in the diagnosis and to pick-up mildly affected persons as early as possible, when they can benefit the most from enzyme replacement therapy.
More Related Videos
Related Concept Videos
Pleiotropy
Animal Mitochondrial Genetics
Lysosomal Hydrolases
Pedigree Analysis
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Sex-linked Disorders

